Literature DB >> 11278486

The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity.

C Chong1, L Tan, L Lim, E Manser.   

Abstract

The p21-activated kinases (PAKs), in common with many kinases, undergo multiple autophosphorylation events upon interaction with appropriate activators. The Cdc42-induced phosphorylation of PAK serves in part to dissociate the kinase from its partners PIX and Nck. Here we investigate in detail how autophosphorylation events affect the catalytic activity of PAK by altering the autophosphorylation sites in both alpha- and betaPAK. Both in vivo and in vitro analyses demonstrate that, although most phosphorylation events in the PAK N-terminal regulatory domain play no direct role in activation, a phosphorylation of alphaPAK serine 144 or betaPAK serine 139, which lie in the kinase inhibitory domain, significantly contribute to activation. By contrast, sphingosine-mediated activation is independent of this residue, indicating a different mode of activation. Thus two autophosphorylation sites direct activation while three others control association with focal complexes via PIX and Nck.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278486     DOI: 10.1074/jbc.M009316200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  99 in total

1.  Conformational switch and role of phosphorylation in PAK activation.

Authors:  G Buchwald; E Hostinova; M G Rudolph; A Kraemer; A Sickmann; H E Meyer; K Scheffzek; A Wittinghofer
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.

Authors:  Sophie Cotteret; Zahara M Jaffer; Alexander Beeser; Jonathan Chernoff
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

3.  GIT1 activates p21-activated kinase through a mechanism independent of p21 binding.

Authors:  Tsui-Han Loo; Yuen-Wai Ng; Louis Lim; Ed Manser
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions.

Authors:  Mary R Stofega; Luraynne C Sanders; Elisabeth M Gardiner; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

Review 5.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

6.  ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.

Authors:  Liangping Yuan; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald
Journal:  Clin Exp Metastasis       Date:  2010-06-06       Impact factor: 5.150

7.  Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome.

Authors:  Lulu Y Chen; Christopher S Rex; Alex H Babayan; Eniko A Kramár; Gary Lynch; Christine M Gall; Julie C Lauterborn
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

8.  p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor.

Authors:  Beatriz Sánchez-Solana; Mona Motwani; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

10.  Myosin 3A kinase activity is regulated by phosphorylation of the kinase domain activation loop.

Authors:  Omar A Quintero; William C Unrath; Stanley M Stevens; Uri Manor; Bechara Kachar; Christopher M Yengo
Journal:  J Biol Chem       Date:  2013-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.